SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

University of Iowa Implants State's 1st SynCardia Total Artificial Heart

58-Year-Old Man Out of Bed and Walking Less Than a Week After Surgery to Replace His Failing Heart

James Davis, MD, cardiothoracic surgeon at UI Heart and Vascular Center, performed the state's first implant of SynCardia's Total Artificial Heart on July 6, 2011. James Davis, MD, cardiothoracic surgeon at UI Heart and Vascular Center, performed the state's first implant of SynCardia's Total Artificial Heart on July 6, 2011. TUCSON, Ariz. – July 21, 2011 – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Iowa Hospitals and Clinics - the only comprehensive academic medical center in Iowa - has performed the state's first implant of the Total Artificial Heart.

"This is a very efficient pump, and it does a great job pumping blood," said James Davis, MD, the cardiothoracic surgeon who implanted the device. "It's similar to a normal heart in terms of its capacity."

The 58-year-old male patient had been suffering from ischemic cardiomyopathy and was implanted with SynCardia's Total Artificial Heart on July 6. Just five days after surgery, the patient was extubated, out of bed, and walking around the ICU.  

UI Hospitals and Clinics has received Institutional Review Board (IRB) approval to participate in the FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom® portable driver. Weighing 13.5 pounds, the Freedom driver is the first U.S. portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital.

"Our hope is that through the FDA clinical study of the Freedom portable driver, stable Total Artificial Heart patients who meet study criteria will be able to leave the hospital and wait for a matching donor heart at home with their families," said Jennifer Goerbig-Campbell, MD, a cardiologist with UI Heart and Vascular Center.

###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

Search offcanvas